ABSTRACT: Two complexes dichloro(9,9-dihexyl-4,5-diazafluorene)platinum(II) (Pt-DHF) and dichloro(9,9-dihexyl-4,5-diazafluorene)palladium(II) (Pd-DHF) were synthesized and their in vivo antitumour activity was investigated using an athymic nude mice model xenografted with human Hep3B carcinoma cells. Pt-DHF-and Pd-DHF-treated groups showed significant tumour growth inhibition (with about 9-fold and 3-fold tumour growth retardation) when compared with the vehicle control group. The liver toxicology effects on the animals of the two compounds were investigated. Pt-DHF and Pd-DHF-treated groups had a lower alanine transaminase and aspartate transaminase values than those of the vehicle treated group as the animals from the vehicle control group had very heavy hepatoma burden. We assume that both complexes could be further investigated as effective antitumour agents and it is worthwhile to study their underlying working mechanism.
Introduction
Metal complexes are important in the development of antitumour drugs because of the interaction between metal complexes with biomolecules in human body and the high stability of their final products under various conditions. Metal complexes have been employed in antitumour therapy since the discovery of the cytotoxicity of cisplatin (cis-Pt(NH 3 ) 2 Cl 2 ) by Rosenberg and co-workers in the late 1960s [1, 2] . Cisplatin was the first identified member of the platinum-based chemotherapeutic drugs. It has been applied clinically for more than three decades in oncology [2, 3] . The introduction of cisplatin to the antitumour therapy has initiated the design and synthesis of metal complexes including platinum and palladium to improve the therapeutic activity of the antitumour drugs.
Pt(II) ion has a strong binding ability to sulfur. After taking the Pt(II)-based drug in the human body, there is a high potential for binding with sulfur-donor biomolecules, which can be found in peptides, proteins and enzymes. The interaction of Pt(II) complexes with S-containing biomolecules can lead to strong cytotoxicity [4, 5] . The anti-tumour activity of Pt(II)-based drugs can be due to the interaction between the metal complex and genomic DNA [4, 6] .
Owing to the structural similarities and significant overlap of the coordination chemistry for palladium and platinum, these two metals are closely related [7] .
Palladium related complexes have also been investigated intensively in the field of medicinal chemistry [8, 9] . Motswainyana and co-workers examined the anticancer property of the synthesized palladium(II) and platinum(II) complexes: It appears that most of these studies have focused on in vitro anticancer analysis while in vivo antitumour studies including tumour size reduction evaluation have been infrequently reported. In our present study, two platinum(II) and palladium(II) complexes with 9,9-dihexyl-4,5-diazafluorene (DHF) derivatives were synthesized and their in vivo antitumour activities were investigated using an athymic nude mice model xenografted with human Hep3B carcinoma cells.
Results and discussion

Chemistry
The chemical structures and the synthetic protocols of the novel diazafluorene-based organic compounds are shown in Scheme 1.
9,9-Dihexyl-4,5-diazafluorene (DHF) was prepared using the method reported in the previous paper [16] . Platinum(II)-9,9-dihexyl-4,5-diazafluorene (Pt-DHF) complex was obtained from DHF by treatment with K 2 PtCl 4 in water solution in the presence of a catalytic amount of conc. HCl in a high yield of 80% [17] , while palladium-9,9-dihexyl-4,5-diazafluorene (Pd-DHF) congener was successfully synthesized using Na 2 PdCl 4 in CH 2 Cl 2 solution in 86% yield [18] .
These air-stable compounds were isolated in high purity as golden or brown solids by column chromatography on silica gel eluting with CH 2 Cl 2 . These compounds were fully characterized by NMR (both 1 H and 13 C) spectroscopy (see Supporting Information) and fast atom bombardment mass spectrometry (FAB-MS). Both of them can afford good single crystals for X-ray diffraction analysis from their solid samples ( Fig. 1 and 2 ). Based on our prior results with 4,5-diazafluoren-9-one as the coordinated ligands which showed very poor solubility in common solvents [18] , we have purposely substituted the oxo group with long alkyl chains at the 9-position of fluorene in the present study to tune the solubility and hydrophobility of the metal complexes. The ligand DHF has been shown to possess a certain level of antitumour activity in athymic nude mice xenografted with human Hep3B carcinoma cells [16] . Since metal ions are promising candidates that have been successfully used for anticancer therapy [19] , the potential antitumour potency was further investigated after the incorporation of metal ions (Pt and Pd) into the DHF. 
Preliminary animal experiments
Athymic nude mice xenografted with human Hep3B carcinoma cells were These results suggest the importance for the incorporation of Pt and Pd into the DHF as antitumour agents. Noticeably, extensively necrotic feature could be detected from the Pt-DHF-treated mice (Fig. 5B) . For both the vehicle control group (Fig. 5A ) and the Pd-DHF-treated group (Fig. 5C ), tumour section displayed high cellular integrity.
In order to demonstrate whether the Pt-DHF and Pd-DHF at 10 mg kg −1 body weight has any possible toxicology effects on the animals under the current therapeutic protocol, hematoxylin and eosin (H and E) staining of liver sections ( Fig. 5A-C) and plasma liver functional enzyme analysis including ALT and AST (Fig. 6 ) were investigated. Neither necrotic nor damaged tissue could be observed from the histochemistry study of liver sections from sacrificed mice in all treated groups (Fig. 5D-F ). Enzymatic levels were determined by the IDEXX laboratories machine using its veterinary biochemistry assay kits and expressed as units per litre. Results represent the mean±SD.
Conclusions
We have demonstrated that the Pt-DHF and Pd-DHF complexes showed a much stronger in vivo antitumour activity than the DHF compound. The complexes-treated groups had a lower ALT and AST values than those of the vehicle treated group, suggesting that they exerted low liver toxicity under the therapeutic dosage (10 mg kg -1 ). Our work here implies the importance of metal containing drugs for further antitumour regimen development. We assume that it is worthwhile to further study their underlying working mechanism and compare with those conventional metal containing antitumour regimens.
Experimental section
Chemistry
General methods
All of the manipulations were performed under a dry nitrogen atmosphere by using Schlenk techniques. Solvents were dried by standard methods and distilled prior to use. All reagents and chemicals, unless otherwise stated, were purchased from commercial sources and used without further purification.
Separation and purification of products were achieved by column chromatography on silica gel. The ligand precursor DHF was prepared according to the literature method [16] .
Physical measurements
NMR spectra were measured in deuterated solvents as the lock and reference on a Bruker AV 400 instrument with 1 H and 13 C NMR chemical shifts quoted relative to tetramethylsilane standard. The positive-ion fast atom bombardment (FAB) mass spectra were obtained using Finnigan-MAT SSQ710 mass spectrometer. Crystals of our compounds suitable for X-ray diffraction studies were grown by slow evaporation of its solution in dichloromethane/hexane at room temperature and were mounted on a glass fibre. Geometric and intensity data were collected by using graphite-monochromated MoKα radiation (λ = 0.71073 Å ) on a Bruker Axs SMART 1000 CCD diffractometer. The collected frames were processed with the software SAINT [20] and an absorption correction (SADABS) [21] was applied to the collected reflections. The structures of all compounds were solved by the Direct methods (SHELXTL TM ) [22] in conjunction with standard difference Fourier techniques and subsequently refined by full matrix least-squares analyses on F 2 . All non-hydrogen atoms were assigned with anisotropic displacement parameters. Hydrogen atoms were generated in their idealized positions and allowed to ride on their respective parent carbon atoms. 
Synthesis of Pt-DHF
Synthesis of Pd-DHF
Preliminary animal experiments
Cell culture
Human hepatoma Hep3B cells were removed from the sterile cell culture flasks with trypsin and neutralized with fetal bovine serum. After washing with phosphate buffered saline and centrifugation, cells were re-suspended in complete cell culture medium [16, [23] [24] [25] . and asparate aminotransferase (AST) were measured by the Vet biochemistry assay kit for the IDEXX laboratories machine to determine the hepatoma burden from the mice [16, 25] .
Preliminary in vivo athymic nude mice experiment
